LEGRAND, Catherine

Email Alert RSS Feed

Profile

Full Name
LEGRAND, Catherine
Email
catherine.legrand@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-18 of 18 (Search time: 0.005 seconds).

Issue DateTitleContributor(s)TypeCat.
12022On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomesDe Backer, Mickael; LEGRAND, Catherine; Peron, Julien; Lambert, Alexandre; BUYSE, MarcJournal ContributionA1
22022Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpointBarrado, Leandro Garcia; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
32021A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisonsCantagallo, Eva; De Backer, Mickael; KICINSKI, Michal; Ozenne, Brice; Collette, Laurence; LEGRAND, Catherine; BUYSE, Marc; Peron, JulienJournal ContributionA1
42021Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialDeclercq , Jozefien; Van Damme, Karel F. A.; De Leeuw, Elisabeth; Maes, Bastiaan; Bosteels, Cedric; Tavernier, Simon J.; De Buyser, Stefanie; Colman, Roos; Hites, Maya; Verschelden, Gil; Fivez, Tom; Moerman , Filip; Demedts, Ingel K.; Dauby, Nicolas; De Schryver, Nicolas; Govaerts , Elke; Vandecasteele, Stefaan J.; Van Laethem, Johan; Anguille, Sebastien; VAN DER HILST, Jeroen; Misset, Benoit; Slabbynck, Hans; Wittebole, Xavier; Lienart, Fabienne; LEGRAND, Catherine; BUYSE, Marc; Stevens, Dieter; Bauters, Fre; Seys, Leen J. M.; Aegerter, Helena; Smole, Ursula; Bosteels, Victor; Hoste , Levi; Naesens, Leslie; Haerynck, Filomeen; Vandekerckhove, Linos; Depuydt, Pieter; van Braeckel, Eva; Rottey, Sylvie; Peene, Isabelle; Van Der Straeten, Catherine; Hulstaert, Frank; Lambrecht, Bart N.Journal ContributionA1
52020Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European countryMOLENBERGHS, Geert; BUYSE, Marc; ABRAMS, Steven; HENS, Niel; Beutels, Philippe; FAES, Christel; VERBEKE, Geert; Van Damme, Pierre; Goossens, Herman; NEYENS, Thomas; HERZOG, Sereina; Theeten, Heidi; Pepermans, Koen; Abad, Ariel Alonso; VAN KEILEGOM, Ingrid; Speybroeck, Niko; LEGRAND, Catherine; De Buyser, Stefanie; Hulstaert, FrankJournal ContributionA1
62017Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical TrialsDesmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
72016Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group TrialTimmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
82016Testing for decreasing heterogeneity in a new time-varying frailty modelMunda, Marco; LEGRAND, Catherine; DUCHATEAU, Luc; JANSSEN, PaulJournal ContributionA1
92014Linear mixed-effects models for central statistical monitoring of multicenter clinical trialsDesmet, L.; Venet, D.; Doffagne, E.; Timmermans, C.; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
102012A statistical approach to central monitoring of data quality in clinical trialsVenet, David; Doffagne, Erik; BURZYKOWSKI, Tomasz; Beckers, Francois; Tellier, Yves; Genevois-Marlin, Eric; Becker, Ursula; Bee, Valerie; Wilson, Veronique; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
112009Validation of prognostic indices using the frailty modelLEGRAND, Catherine; DUCHATEAU, Luc; JANSSEN, Paul; Ducrocq, V.; SYLVESTER, RichardJournal ContributionA1
122007Comparison of different estimation procedures for proportional hazards model with random effectsCORTINAS ABRAHANTES, Jose; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; JANSSEN, Paul; Ducrocq, Vincent; DUCHATEAU, LucJournal ContributionA1
132006Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trialLEGRAND, Catherine; DUCHATEAU, Luc; SYLVESTER, Richard; JANSSEN, Paul; van der Hage, JA; van de Velde, CJH; Therasse, PJournal ContributionA1
142005Assessing heterogeneity in multicenter clinical trials using the frailty modelLEGRAND, CatherineTheses and DissertationsT1
152005A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards modelLEGRAND, Catherine; Ducrocq, V; JANSSEN, Paul; SYLVESTER, Richard; DUCHATEAU, LucJournal ContributionA1
162003Does it matter where you are treated? A treatment outcome study based on clinical trial dataLEGRAND, Catherine; DUCHATEAU, Luc; SYLVESTER, Richard; JANSSEN, PaulJournal ContributionM
172002The shared frailty model and the power for heterogeneity tests in multicenter trialsDUCHATEAU, Luc; JANSSEN, Paul; LEGRAND, Catherine; LINDSEY, Patrick; NGUTI, Rosemary; SYLVESTER, RichardJournal ContributionA1
182002Treatment outcome studies: pitfalls in curent methods and practiceLEGRAND, Catherine; SYLVESTER, Richard; DUCHATEAU, Luc; JANSSEN, Paul; Therasse, PatrickJournal ContributionA1